Brief: Interpace Biosciences Receives Nasdaq Deficiency Notice Due To Delayed Filing Of Form 10-Q

Interpace Biosciences

19/11/2020 21:14

Nov 19 (Reuters) - Interpace Biosciences Inc  IDXG.O :
    * INTERPACE BIOSCIENCES RECEIVES NASDAQ DEFICIENCY NOTICE
DUE TO
DELAYED FILING OF FORM 10-Q; NO IMMEDIATE IMPACT ON LISTING

Source text for Eikon:  ID:nGNX9NBBpv 
Further company coverage:  IDXG.O 

 ((Reuters.Briefs@thomsonreuters.com;))